Application value of eosinophil cationic protein in the diagnosis and treatment of chronic obstructive pulmonary disease

You-you YU,Xiu-jun PAN
2013-01-01
Abstract:Objective To detect the level of serum eosinophil cationic protein(ECP)in the patient with chronic obstructive pulmonary disease(COPD),to discuss the differential diagnostic value in the diagnosis of COPD and the relationship between the change of ECP level and chronic COPD.Methods The serum ECP of fifty-three acute COPD patients and forty acute asthma patients were measured with fluorescent enzyme immunoassay,and compared and analyzed with the corresponding values of control group consisting of thirty-nine patients.Results The ECP level in the group of COPD patients(48.09±31.33)μg/L was significantly higher than that in the control group(7.83±3.65)μg/L,but was significantly lower than that in asthma group(97.17±54.30)μg/L,(P 0.01).By ROC curve analysis,serum ECP level reached 66.85ug/L with the maximum sensitivity(88.2%)and specificity(88.6%)of the differential diagnostic value in the diagnosis of COPD and asthma.In COPD patients,ECP level increased with the aggravation of the disease,especially in serious patients and extremely serious patients(P 0.05).The ECP level in extremely serious COPD patients was slightly higher than that in serious patient with no significance(P0.05).Conclusion Serum ECP level increases in COPD patients and is relevant with the severity of the disease.Although in some cases,the symptoms of COPD and asthma are very similar,the increase of ECP level in COPD patients is lower than that in asthma patients.Therefore,it is of considerable referential importance in diagnosing COPD,monitoring patients' condition,using drug rationally,and evaluating the effect of anti-inflammatory treatment by monitoring ECP level.
What problem does this paper attempt to address?